What the pulmonary specialist should know about the new inhalation therapies

A collaboration of multidisciplinary experts on the delivery of pharmaceutical aerosols was facilitated by the European Respiratory Society (ERS) and the International Society for Aerosols in Medicine (ISAM), in order to draw up a consensus statement with clear, up-to-date recommendations that enabl...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	The European respiratory journal Ročník 37; číslo 6; s. 1308
Hlavní autoři:	Laube, B L, Janssens, H M, de Jongh, F H C, Devadason, S G, Dhand, R, Diot, P, Everard, M L, Horvath, I, Navalesi, P, Voshaar, T, Chrystyn, H
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England 01.06.2011
Témata:	Acquired Immunodeficiency Syndrome - drug therapy Administration, Inhalation Advisory Committees - standards Aged Aged, 80 and over Asthma - drug therapy Child Child, Preschool Cystic Fibrosis - drug therapy Familial Primary Pulmonary Hypertension Humans Hypertension, Pulmonary - drug therapy Lung Diseases - drug therapy Nebulizers and Vaporizers Physician-Patient Relations Pulmonary Disease, Chronic Obstructive - drug therapy Pulmonary Medicine - standards Respiration, Artificial - methods Respiratory Therapy - standards
ISSN:	1399-3003, 1399-3003
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!